Buffington Mohr McNeal’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,140
Closed -$391K 363
2019
Q1
$391K Sell
4,140
-650
-14% -$56.8K 0.13% 101
2018
Q4
$307K Sell
4,790
-11,805
-71% -$871K 0.12% 106
2018
Q3
$1.49M Sell
16,595
-670
-4% -$59.2K 0.51% 46
2018
Q2
$1.37M Sell
17,265
-1,005
-6% -$83.4K 0.51% 44
2018
Q1
$1.63M Sell
18,270
-935
-5% -$89.8K 0.62% 41
2017
Q4
$2M Sell
19,205
-510
-3% -$57.5K 0.77% 39
2017
Q3
$1.94M Sell
19,715
-320
-2% -$43.6K 0.75% 40
2017
Q2
$2.6M Sell
20,035
-15
-0.1% -$1.84K 1.03% 30
2017
Q1
$2.5M Buy
20,050
+5
+0% +$598 1.1% 32
2016
Q4
$2.32M Sell
20,045
-35
-0.2% -$3.9K 0.89% 40
2016
Q3
$2.1M Sell
20,080
-415
-2% -$44.9K 0.88% 39
2016
Q2
$2.02M Sell
20,495
-350
-2% -$36.2K 0.89% 33
2016
Q1
$2.09M Buy
20,845
+6,210
+42% +$639K 0.92% 30
2015
Q4
$1.75M Buy
14,635
+12,290
+524% +$1.42M 0.94% 26
2015
Q3
$254K Buy
2,345
+1,395
+147% +$173K 0.17% 54
2015
Q2
$109K Buy
+950
New +$109K 0.06% 91

Other funds holding CELG

Buffington Mohr McNeal's CELG Position: Q2 2019 in Review

Buffington Mohr McNeal sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 4,140 shares — an estimated $391K sold.

Buffington Mohr McNeal first reported a position in CELG in Q2 2015 and held it in 16 quarters. The position peaked at $2.6M in Q2 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Buffington Mohr McNeal reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Buffington Mohr McNeal sold 4,140 Celgene Corp shares in Q2 2019, an estimated $391K.
  • Buffington Mohr McNeal first reported a position in Celgene Corp in Q2 2015 and held it in 16 quarters.
  • Buffington Mohr McNeal's Celgene Corp position peaked at $2.6M in Q2 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Buffington Mohr McNeal's 13F filing for Q2 2019, filed 31 Jul 2019.